BioCentury
ARTICLE | Company News

Ambrx, Eli Lilly in protein and antibody deal

December 18, 2007 1:37 AM UTC

Ambrx (San Diego, Calif.) and LLY partnered to discover and develop protein and antibody therapeutics for multiple disease areas, including metabolic and CNS indications, using Ambrx's ReCODE protein ...